Prestige II with Havlogen (Canada)

This page contains information on Prestige II with Havlogen for veterinary use.
The information provided typically includes the following:
  • Prestige II with Havlogen Indications
  • Warnings and cautions for Prestige II with Havlogen
  • Direction and dosage information for Prestige II with Havlogen

Prestige II with Havlogen

This treatment applies to the following species:
Manufacturer: Merck Animal Health

Equine Vaccine

EQUINE RHINOPNEUMONITIS - INFLUENZA VACCINE

KILLED VIRUS

Description

A combination of inactivated, concentrated, adjuvanted, tissue culture origin equine herpesviruses types 1 and 4 (EHV-1 and EHV-4) and equine influenza virus type H3N8 strains (EIV A/Equine2/Kentucky/93 American, EIV A/Equine2/Kentucky/02 American, EIV A/Equine2/Newmarket/2/93 Eurasian). Intervet serological data suggest influenza cross protection against certain U.S. and European strains, including Kentucky 91, 93, 99, 02, Ohio 03, Newmarket/1/93, Newmarket/2/93, Suffolk 89 and South Africa 03.

Prestige II with Havlogen Indications

For vaccination of healthy horses, 6 months of age or older, as an aid in the control of respiratory disease caused by EHV-1 and EHV-4 and EIV; and as an aid in reduction of virus shedding of EHV-1 and EIV. Duration of Immunity (DOI) has been shown to be at least 6 months for EIV. Foals nursing immune-dams should be vaccinated when maternal antibody levels will allow active immunization.

DOSE: For primary vaccination, aseptically administer 1 mL intramuscularly, repeat with a single dose in 3 - 4 weeks. Annual vaccination is recommended. A booster dose can be administered at more frequent intervals based upon individual horse or farm disease risk assessment or any time epidemic conditions exist or are reported. Consult your veterinarian.

CAUTIONS: Store at 2-7°C (35-45°F). Shake well before using. Use the entire contents when first opened. Do not vaccinate within 21 days before slaughter. Local reactions may occur if this product is given subcutaneously. Inject deep into the muscle only. Anaphylactoid reactions may occur. Antidote: Epinephrine.

WARNING: Needle is sharp and may cause injury to self or animals if not handled properly or disposed of properly. Care should be used to avoid injecting your own fingers, hands, or other body parts. Accidental injection can cause serious local reactions. Contact a physician immediately if an accidental injection occurs.

ANTIBIOTICS: Product contains neomycin, polymyxin B, nystatin and gentamicin.

PRESERVATIVE: Thimerosal is added as preservative.

FOR USE IN ANIMALS ONLY

*Adjuvant-Intervet’s Proprietary Technology.

Manufactured by: Intervet Inc., Omaha, Nebraska 68103, U.S.A.

U.S. Veterinary License No. 165A

For: Intervet Canada Corp., 16750, route Transcanadienne, Kirkland QC, H9H 4M7

For technical enquiries, call toll free 1 888 306-0069.

™ Trademark of Intervet International B.V., used under license by Intervet Canada Corp.

 

 

PRODUCT CODE

 

10 Doses

Ten 1 mL Syringes with Separate Sterile Needles

030791

71-414132

10 Doses

10 mL

030872

71-414132

NAC No.: 12081513

MERCK ANIMAL HEALTH
Intervet Canada Corp.

16750 ROUTE TRANSCANADIENNE, KIRKLAND, QC, H9H 4M7
Order Desk:   514-428-7013
Toll-Free:   866-683-7838
Fax:   Toll-free 888-498-4444; local 514-428-7014
Website:   www.merck-animal-health.ca
Every effort has been made to ensure the accuracy of the Prestige II with Havlogen information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the Canadian product label or package insert.

Copyright © 2014 North American Compendiums. Updated: 2014-07-28

(web5)